N. Lecointe

发表

Activated, but not resting human Th2 cells, in contrast to Th1 and T regulatory cells, produce soluble ST2 and express low levels of ST2L at the cell surface

S. Tominaga, V. Boulay, H. Yssel, 2002, European journal of immunology.

A third tal-1 promoter is specifically used in human T cell leukemias

R. Berger, O. Bernard, C. Larsen, 1992, The Journal of experimental medicine.

Expression of TAL-1 proteins in human tissues.

D. Mason, K. Pulford, M Jones, 1995, Blood.

Distinct DNase-I hypersensitive sites are associated with TAL-1 transcription in erythroid and T-cell lines.

P. Romeo, M. Vinit, D. Mathieu-Mahul, 1994, Blood.

Loss of TAL‐1 protein activity induces premature apoptosis of Jurkat leukemic T cells upon medium depletion.

P. Romeo, U. Hibner, H. Jouault, 1995, The EMBO journal.

Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5' part of the tal-1 gene.

R. Berger, O. Bernard, C. Larsen, 1991, Oncogene.

GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene.

O. Bernard, P. Romeo, C. Larsen, 1994, Oncogene.

Molecular analysis of an unstable genomic region at chromosome band 11q23 reveals a disruption of the gene encoding the α2 subunit of platelet-activating factor acetylhydrolase (Pafah1a2) in human lymphoma

B. Young, J. Meerabux, M. Ebihara, 1999, Oncogene.

Expression of orf1 from the Bacillus thuringiensis NRD-12 cry2Aa1 Operon

R. Frutos, M. Royer, W. Moar, 1999, Current Microbiology.